Spatially encoded biological assays
The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.
1. A composition comprising an array comprising a planar substrate and a plurality of capture probes, wherein:
each of the plurality of capture probes comprises: (i) a biological target-binding domain, (ii) a coding tag comprising a nucleic acid sequence, and (iii) a primer binding site;
the biological target-binding domain of each capture probe of the plurality of capture probes comprises a nucleic acid sequence complementary to a portion of an mRNA;
the nucleic acid sequence of the coding tag of each of the plurality of capture probes identifies a unique location on the planar substrate and does not selectively hybridize to the mRNA that binds to the biological target-binding domain of the capture probe; and
the plurality of capture probes are directly immobilized on the planar substrate in a pre-defined pattern.
2. The composition of claim 1 , wherein the pre-defined pattern is a pattern of ink jet-printed or photolithographic features.
3. The composition of claim 1 , wherein 5′ ends of each of the plurality of capture probes are attached to the planar substrate.
4. The composition of claim 1 , wherein the planar substrate comprises a slide.
5. The composition of claim 1 , wherein the plurality of capture probes comprises at least 1,000 capture probes.
6. The composition of claim 5 , wherein the plurality of capture probes comprises at least 10,000 capture probes.
7. The composition of claim 1 , wherein the array further comprises a fiducial marker.
8. The composition of claim 1 , wherein the composition further comprises a biological sample disposed on the array.
9. The composition of claim 8 , wherein the biological sample is a tissue sample.
10. The composition of claim 9 , wherein the tissue sample comprises a tissue section.
11. The composition of claim 10 , wherein the tissue section is a fixed tissue section.
12. The composition of claim 11 , wherein the fixed tissue section is a formalin-fixed paraffin-embedded tissue sample.
13. The composition of claim 9 , wherein the tissue sample is a fresh, frozen tissue sample.
14. The composition of claim 1 , wherein the composition further comprises the mRNA selectively hybridized to a biological target-binding domain of at least one of the plurality of capture probes.
15. The composition of claim 1 , wherein the biological target-binding domain is the same for each of the plurality of capture probes.
16. A composition comprising (i) an array comprising a planar substrate and a plurality of capture probes, and (ii) a tissue sample, wherein:
the tissue sample is disposed on the array;
each of the plurality of capture probes comprises: (i) a biological target-binding domain (ii) a coding tag comprising a nucleic acid sequence, and (iii) a primer binding site;
the biological target-binding domain of each probe of the plurality of capture probes comprises a nucleic acid sequence complementary to a portion of an mRNA;
the nucleic acid sequence of the coding tag of each of the plurality of capture probes identifies a unique location on the planar substrate; and
the plurality of capture probes are directly immobilized on the planar substrate in a pre-defined pattern.
17. The composition of claim 16 , wherein the planar substrate comprises a slide.
18. The composition of claim 16 , wherein the plurality of capture probes comprises at least 1,000 capture probes.
19. The composition of claim 16 , wherein the array further comprises a fiducial marker.
20. The composition of claim 16 , wherein the tissue sample comprises a tissue section.
21. The composition of claim 20 , wherein the tissue section is a fixed tissue section.
22. The composition of claim 21 , wherein the fixed tissue section is a formalin-fixed paraffin-embedded tissue sample.
23. The composition of claim 16 , wherein the tissue sample is a fresh, frozen tissue sample.
24. The composition of claim 16 , wherein the composition further comprises the mRNA selectively hybridized to a biological target-binding domain of at least one of the plurality of capture probes.
25. The composition of claim 16 , wherein the nucleic acid sequence of the coding tag of each of the plurality of capture probes does not selectively hybridize to the mRNA.
26. The composition of claim 16 , wherein the biological target-binding domain is the same for each of the plurality of capture probes.